Products & Technology

Raland offers a patient-centric perspective towards product development. We leverage real-world experience to conceive and develop products that improve patient care, comfort, and safety.

One example is the Raland RxFusion™ device, which was conceived by the founder of Raland. As a patient with a condition requiring in-home infusion therapy, he quickly discovered that the method of delivery was cumbersome, prone to improper sequencing, and susceptible to contamination. Seeking a better solution, he started the design of the new infusion device shortly after his initial treatments. From that moment, a company was born with the overarching principle of creating opportunity from adversity.

We are a company committed to discovering, developing and commercializing novel interventional devices. Our primary focus is the patient; providing unique products to treat or cure many afflictions. We currently have two product candidates and a series of preclinical candidates nearing preparation for clinical development:

• RxFusion™ (RTI-001), a device for safe and easier multi-drug infusions is entering a 510k preparation phase;
• BID-01, is an implantable biosensor developed for use in laboratory animals testing;

Additionally, we are continuing to identify the best path forward for the development of BCD-01, RTI-02, LICD-01 and LID-01, for the treatment of a multitude of conditions within the human body.